Mosaic ImmunoEngineering Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CPMV research report →
Companywww.mosaicie.com
Mosaic ImmunoEngineering Inc. , a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. It offers MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in mice, dogs, and humans.
- CEO
- Steven W. King
- IPO
- 2013
- Employees
- 2
- HQ
- Huntington Beach, CA, US
Price Chart
Valuation
- Market Cap
- $5.03M
- P/E
- -7.38
- P/S
- 0.00
- P/B
- -0.66
- EV/EBITDA
- -10.68
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 9.22%
- ROIC
- 9.67%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-687,846 · 25.39%
- EPS
- $-0.10 · 26.92%
- Op Income
- $-616,119
- FCF YoY
- 53.81%
Performance & Tape
- 52W High
- $1.05
- 52W Low
- $0.25
- 50D MA
- $0.67
- 200D MA
- $0.60
- Beta
- -0.67
- Avg Volume
- 337
Get TickerSpark's AI analysis on CPMV
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 18, 22 | KING STEVEN W | other | 0 |
| Feb 18, 22 | FELCYN GLORIA | other | 0 |
| Feb 18, 22 | GARNICK ROBERT L | other | 0 |
| Feb 18, 22 | BAFFI ROBERT | other | 0 |
| Feb 18, 22 | Steinmetz Nicole Franziska | other | 0 |
| Jul 15, 22 | BAFFI ROBERT | other | 51,497 |
| Jul 15, 21 | BAFFI ROBERT | other | 0 |
| May 7, 21 | GARNICK ROBERT L | other | 0 |
| May 7, 21 | FELCYN GLORIA | other | 0 |
| Apr 29, 21 | Steinmetz Nicole Franziska | other | 5,357 |
Our CPMV Coverage
We haven't published any research on CPMV yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CPMV Report →